Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01382719 Completed - Clinical trials for Hypoactive Sexual Desire Disorder

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Start date: June 2011
Phase: Phase 2
Study type: Interventional

This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide, administered subcutaneously on an as-needed basis under conditions of home use, for the treatment of female sexual arousal disorder (FSAD), hypoactive sexual desire disorder (HSDD), or mixed FSAD/HSDD in premenopausal women.

NCT ID: NCT01382563 Completed - Clinical trials for Eosinophilic Esophagitis

Registry for Eosinophilic Gastrointestinal Disorders (REGID)

EoE
Start date: November 2012
Phase:
Study type: Observational

Develop Registry tool

NCT ID: NCT01380704 Completed - Clinical trials for Major Depressive Disorder

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

Start date: June 2011
Phase: Phase 1
Study type: Interventional

This is a multiple-dose study to assess the safety and pharmacology of ABT-436 in physically healthy subjects with mild to moderate depressive symptoms who are not taking any antidepressant medication. Efficacy for treatment of depressive symptoms is not a goal of this study.

NCT ID: NCT01380496 Completed - Clinical trials for To Determine Bioequivalence Under Fed Conditions

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

Start date: November 1999
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the single-dose bioequivalence of Par and Oclassen doxycycline monohydrate 100 mg.

NCT ID: NCT01380483 Completed - Clinical trials for To Determine Bioequivalence Under Fasting Conditions

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

Start date: January 2000
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the single-dose bioequivalence of Par and Oclassen doxycycline monohydrate, 100 mg.

NCT ID: NCT01380457 Completed - Clinical trials for To Determine Bioequivalence Under Fasting Conditions

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

Start date: January 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the rate and extent of absorption of Dronabinol 10 mg capsules verses Marinol.

NCT ID: NCT01377896 Completed - Schizophrenia Clinical Trials

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Start date: July 2010
Phase: N/A
Study type: Observational

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

NCT ID: NCT01377168 Completed - HIV Clinical Trials

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

Start date: May 2014
Phase: Phase 4
Study type: Interventional

This study will recruit 159 HIV-infected men with alcohol use disorders (AUDs). Men will be randomized to receive either oral naltrexone for the treatment of alcohol use disorder or placebo. Men with acute, recent or established HIV infection will receive antiretroviral treatment (ART) and be randomized to oral naltrexone or placebo. The purpose of this study is to see whether use of oral naltrexone improves medication compliance, and therefore HIV viral load suppression, among men with alcohol use disorder. The study will also assess the impact of oral naltrexone on alcohol use behaviors in this population.

NCT ID: NCT01376128 Completed - Panic Disorder Clinical Trials

Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

Start date: March 2008
Phase: N/A
Study type: Observational

The objectives of this survey was to retrospectively collect and evaluate the information on the efficacy and safety of PAXIL tablets ("PAXIL", hereinafter) in pediatric subjects (aged under 18) with panic disorder under conditions of actual use.

NCT ID: NCT01375595 Terminated - Healthy Clinical Trials

Brain Areas Involved in Sound and Spoken Word Memory

Start date: May 26, 2011
Phase: N/A
Study type: Observational

Background: - Studies have shown that animals such as monkeys and dogs have excellent sight and touch memory but perform poorly on sound memory tasks. Human brains have certain areas that are important for speaking and understanding language. These areas may be involved in sound and spoken word memory. Researchers want to study these areas of the brain to find out if the memory for sounds requires brain structures that are usually associated with language learning and are unique to humans. Objectives: - To use magnetic resonance imaging to study areas of the brain involved in sound memory. Eligibility: - Healthy right-handed volunteers between 18 and 50 years of age. They must be native English speakers and have completed high school. Design: - The study requires a screening visit and 1 or 2 study visits to the National Institutes of Health Clinical Center. - At the screening visit, volunteers will have a medical history taken. They will also have physical and neurological exams, and complete a questionnaire. Women of childbearing age will give a urine sample. Participants who have not had a magnetic resonance imaging (MRI) scan in the past year will have one at this visit. - At the second visit, participants will have tests of sound memory. They will listen to a set of nonsense words spoken through earphones and memorize the words. Then they will listen to the words again to judge if the words were part of the earlier list. Participants will have a 1 hour break, then do the sound memory test again. During the second test they will have repetitive transcranial magnetic stimulation (rTMS), which stimulates different regions of the brain. - If the group results from the testing sessions are positive, there will be a third visit. At this visit, participants will have a sound perception test. They will listen to words spoken through earphones and judge whether the words in the pair are the same or different. Participants will have rTMS during these tests as well.